2010
DOI: 10.1177/193229681000400515
|View full text |Cite
|
Sign up to set email alerts
|

Pharmacokinetic Characterization of the Novel Pulmonary Delivery Excipient Fumaryl Diketopiperazine

Abstract: Abbreviations: (ADME) absorption, distribution, metabolism, and excretion, ) area under the curve from time 0 to 480 minutes, (AUC 0-∞ ) area under the curve from time 0 to infinity, (AUC 0-t ) area under the curve from time 0 to t, (BMI) body mass index, (C last ) last observed insulin concentration, (CLD) chronic liver disease, (C max ) maximum observed drug concentration, (DNP) diabetic nephropathy, (FDKP) Bis-3,6(4-fumarylaminobutyl)-2, 5-diketopiperazine, (GFR) glomerular filtration rate, (HPLC) high-per… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
26
0

Year Published

2011
2011
2024
2024

Publication Types

Select...
5
2
1

Relationship

1
7

Authors

Journals

citations
Cited by 41 publications
(27 citation statements)
references
References 11 publications
1
26
0
Order By: Relevance
“…Because of the limited blood sampling taken within this study, extensive serum pharmacokinetic analysis could not be performed. However, the data as reported are consistent with what has been reported in other pharmacokinetic and pharmacokinetic/pharmacodynamic studies where extensive blood sampling was conducted (2,11,14). The serum half-life of FDKP from this study (approximately 140 min) is equivalent to the 150 min half-life reported after IV administration (11), indicating that serum clearance is not absorption dependent.…”
Section: Discussionsupporting
confidence: 89%
See 2 more Smart Citations
“…Because of the limited blood sampling taken within this study, extensive serum pharmacokinetic analysis could not be performed. However, the data as reported are consistent with what has been reported in other pharmacokinetic and pharmacokinetic/pharmacodynamic studies where extensive blood sampling was conducted (2,11,14). The serum half-life of FDKP from this study (approximately 140 min) is equivalent to the 150 min half-life reported after IV administration (11), indicating that serum clearance is not absorption dependent.…”
Section: Discussionsupporting
confidence: 89%
“…Approximately 60% of the emitted dose is delivered to the lungs with a homogeneous distribution bilaterally throughout the lungs. The remaining~40% of the emitted material is not bioavailable as it is ultimately swallowed and enters the gastrointestinal tract, where neither the insulin nor the carrier molecule (FDKP) is absorbed (11). Although the plasma was analyzed for insulin, the low dose administered (due to radioactivity exposure limit) and the meal prior to dosing made it impossible to accurately determine the contribution of the exogenously administered insulin to the total insulin concentration.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Upon inhalation, these microparticles can reach the deep lung where they dissolve rapidly because of the physiological pH, allowing absorption of insulin and FDKP into the systemic circulation with a time to maximum serum insulin concentration of ;12-15 min (8,9). FDKP is excreted unchanged in the urine (10). TI is delivered through the Gen2 inhaler device.…”
mentioning
confidence: 99%
“…The excipient is also absorbed and excreted unchanged in the urine (73). The efficacy of prandially inhaled insulin has been tested in clinical trials as a prandial insulin added to basal insulin (74). Studies have shown that there may be less weight gain than occurs with other insulin regimens.…”
Section: Inhaled Insulinmentioning
confidence: 99%